Grant: Operating Grant - Priority Announcement: ALS Canada Research Fund
McGill University
$0.00
Assesment of somatic mutations and repeat instability in known ALS genes
EF 2012-13
Résumé
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) are two diseases that can occur separately or together in families and individuals. TARDBP, FUS and SOD1 have been reported to cause ALS. Very recently, a large repeat expansion (GGGGCC) in the C9orf72 gene has been reported as the most common cause of familial and sporadic ALS and FTD. We propose to examine the spinal cord of sporadic ALS cases and identify somatic mutation of the c9orf72 repeat and somatic mutations in TARDBP, FUS or SOD1. Identifying such mechanisms may help to better understand the disease and lead to novel therapeutic avenues.
Programme
Operating Grant - Priority Announcement: ALS Canada Research Fund
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
286581
Name
Rouleau Guy A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Amyotrophic Lateral Sclerosis Society of Canada
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
Assesment of somatic mutations and repeat instability in known ALS genes
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$0
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: ALS Canada Research Fund
Keyworddelim
Amyotrophic Laterale Sclerosis; C9orf72; Fus; Repeat Instability; Sod1; Somatic Mutations; Tardbp
Abstract
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) are two diseases that can occur separately or together in families and individuals. TARDBP, FUS and SOD1 have been reported to cause ALS. Very recently, a large repeat expansion (GGGGCC) in the C9orf72 gene has been reported as the most common cause of familial and sporadic ALS and FTD. We propose to examine the spinal cord of sporadic ALS cases and identify somatic mutation of the c9orf72 repeat and somatic mutations in TARDBP, FUS or SOD1. Identifying such mechanisms may help to better understand the disease and lead to novel therapeutic avenues.
Competitiondate
201303
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Rouleau, Guy A
Approvedterm
2 ans 0 mois